1.0Trade Brains Featureshttps://tradebrains.in/featuresPTI Newshttps://tradebrains.in/features/author/ptinews/rich600338<blockquote class="wp-embedded-content" data-secret="Sok8XxUlZO"><a href="https://tradebrains.in/features/biz-zydus-cadila/">Zydus gets nod to conduct Phase II clinical study in patients with CAPS in Australia</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://tradebrains.in/features/biz-zydus-cadila/embed/#?secret=Sok8XxUlZO" width="600" height="338" title="“Zydus gets nod to conduct Phase II clinical study in patients with CAPS in Australia” — Trade Brains Features" data-secret="Sok8XxUlZO" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> New Delhi, Dec 13 (PTI) Drug firm Zydus Cadila on Monday said it has received approval to commence Phase II clinical study of its upcoming product with patients suffering with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia. The company has received permission to initiate the Phase II clinical study of its NLRP3 inhibitor ‘ZYIL1’ in patients […]